dx 9065a has been researched along with fibrinogen in 2 studies
| Studies (dx 9065a) | Trials (dx 9065a) | Recent Studies (post-2010) (dx 9065a) | Studies (fibrinogen) | Trials (fibrinogen) | Recent Studies (post-2010) (fibrinogen) |
|---|---|---|---|---|---|
| 92 | 7 | 8 | 34,477 | 1,707 | 7,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoshima, K; Asakura, H; Ikeda, T; Jokaji, H; Kumabashiri, I; Matsuda, T; Morishita, E; Saito, M; Uotani, C; Yamazaki, M | 1 |
| Hara, T; Ishihara, H; Iwamoto, M; Tanabe, K; Yokoyama, A | 1 |
2 other study(ies) available for dx 9065a and fibrinogen
| Article | Year |
|---|---|
Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
Topics: Administration, Oral; Animals; Anticoagulants; Disseminated Intravascular Coagulation; Drug Evaluation, Preclinical; Endotoxins; Factor Xa Inhibitors; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Kidney Glomerulus; Male; Naphthalenes; Partial Thromboplastin Time; Platelet Count; Propionates; Prothrombin Time; Rats; Rats, Wistar; Thromboplastin | 1994 |
DX-9065a, an orally active, specific inhibitor of factor Xa, inhibits thrombosis without affecting bleeding time in rats.
Topics: Animals; Anticoagulants; Arteriovenous Shunt, Surgical; Bleeding Time; Blood Coagulation; Disseminated Intravascular Coagulation; Factor Xa Inhibitors; Fibrin Fibrinogen Degradation Products; Fibrinogen; Male; Naphthalenes; Platelet Count; Propionates; Rats; Rats, Wistar; Thromboplastin | 1995 |